Gregory Kornhaber

Gregory Kornhaber has extensive work experience, starting with their current role as Principal Engineer at Avanos Medical since February 2022. Prior to this, they served as the Director of Quality and Alliances at OrthogenRx from February 2017 to February 2022. From May 2016 to January 2017, they held the position of Chief Operations Officer at Nexomics Biosciences, and from January 2014 to May 2016, they served as the Director of Operations and Business Development at the same company. Gregory also served as the Co-Chair at NJ ACS NMR Topical Meeting from January 2014 to August 2015. Before that, they worked as an Assistant Research Professor at Rutgers, The State University of New Jersey from June 2009 to January 2014, where they were the project manager for the Northeast Structural Genomics Consortium, a large multi-institutional NIH funded research organization. Their earlier experience includes roles such as Associate Director of Business Development at ExSAR Corporation from August 2007 to May 2009, where they were involved in consultative sales and project management, and as an NJCST Postdoctoral Fellow at the same company from August 2005 to July 2007.

Gregory Kornhaber holds a PhD from Rutgers University, where they completed the UMDNJ-Rutgers Joint Program in the Molecular Biosciences. Prior to their doctoral studies, they obtained a Bachelor's degree in Biochemistry from the University at Albany, SUNY. The specific start and end years for both degrees were not provided.